Pharma Industry News

Sarepta looks to get 2nd experimental Duchenne drug approved

Sarepta Therapeutics is working quickly to get a new drug approved to treat Duchenne muscular dystrophy, a rare, inherited disease that causes muscles to weaken.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]